IP Verse

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions - EP3320919

The patent EP3320919 was granted to Boehringer Ingelheim Animal Health USA on May 27, 2020. The application was originally filed on Dec 28, 2006 under application number EP17208901A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3320919

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP17208901A
Filing Date
Dec 28, 2006
Status
Granted And Under Opposition
Apr 24, 2020
Grant Date
May 27, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELANCOFeb 25, 2021POTTER CLARKSONADMISSIBLE
LABORATORIOS HIPRAFeb 24, 2021GRUNECKER PATENTADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONCA2784260
OPPOSITIONEP0784685
OPPOSITIONEP1926496
OPPOSITIONGB2282811
OPPOSITIONUS2003170270
OPPOSITIONUS6001370
OPPOSITIONUS60755015
OPPOSITIONUS6703023
OPPOSITIONUS7122192
OPPOSITIONWO0001409
OPPOSITIONWO0116330
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2007076520
OPPOSITIONWO9307898
OPPOSITIONWO9418311

Non-Patent Literature (NPL) Citations (41) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Alexopoulos C., S.K. Kritasb, C.S. Kyriakisc, E. Tzikac, S.C. Kyriakisc, "Sow performance in an endemic ally porcine reproductive and respiratory syndrome (PRRS)-infected farm aftersow vaccination with an attenuated PRRS vaccine", Veterinary Microbiology, (20050000), vol. 111, pages 151 - 157, XP055789515
OPPOSITION- Anonymous, "Combination Vaccine", National Hog Farmer, (20031215), vol. 48, page 1, XP055802169
OPPOSITION- Anonymous, "Ingelvac CircoFLEX® The first FLEX Family vaccine for PCV2 protection in a single injection", Boehringer Ingelheim Vetmedica, (20180817), pages 1 - 3, Boehringer Ingelheim Vetmedica, URL: https://www.bi-vetmedica.com/species/swine/products/flex_vaccines/circoflex.html, (20210506), XP055802163
OPPOSITION- A. P. Schinckel, et al, "Analysis of Pig Growth from Birth to Sixty Days of Age", Swine Research Report. Purdue University, American Registry of Professional Animal Scientists, (20030101), pages 57 - 67, Swine Research Report. Purdue University, URL: http://www.ansc.purdue.edu/swine/swineday/sday03/10.pdf, (20160602), XP055277371
OPPOSITION- A. Urniza, Et Al., "Abstract No: P.07-09 DURATION OF IMMUNITY STUDY IN PIGS VACCINATED WITH AN INACTIVATED/ADJUV ANTED VACCINE 'CHIMERIC PORCINE CIRCOVIRUS TYPE 1/TYPE 2' IN FRONT OF A CHALLENGE WITH PCV2 EUROPEAN STRAIN", Clinical and Vaccine Immunology, American Society for Microbiology, (20060101), vol. 2, ISSN 1556-6811, page 108, XP055446549
OPPOSITION- Baculovirus Expression Vector System Manual, XP002621775
OPPOSITION- BLANCHARD et al., "Protection of swine against post-weaning multisystemic wastingsyndrome (PMWS) by porcine circovims type 2 (PCV2) proteins", Vaccine, (20030000), vol. 21, pages 4565 - 4575, XP055789503
OPPOSITION- Blanchard, Et Al., "Protection of swine against post-weaning multisystemic wastingsyndrome (PMWS) by porcine circovims type 2 (PCV2) proteins", Vaccine, (20030101), vol. 21, pages 4565 - 4575, XP055789503
OPPOSITION- BOGA JOSE A ET AL, "A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection", Journal of General Virology, (19970101), vol. 78, no. 9, ISSN 0022-1317, pages 2315 - 2318, XP002450362
OPPOSITION- C Charreyre, A Brun, C Aerberle, L Boeuf, P Brocard And G Chappuis, "Vaccination challenge trials with an inactivated vaccine against PRRS", Proceedings of the 15th IPVS Congress, (19980705), page 1392, XP055525284
OPPOSITION- Huiying Fan et al, "Baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", Proc. 2nd Asian Pig Vet. Soc. Congress, (20050101), pages 186 - 188, XP055292703
OPPOSITION- Jiwoon Jeong et al, "Comparative efficacy of concurrent administration of a porcine circovirus type 2 (PCV2) vaccine plus a porcine reproductive and respiratory syndrome virus (PRRSV) vaccine from two commercial sources in pigs challenged with both viruses", J. Swine Health and Production, (20160601), vol. 24, pages 130 - 141, XP055525287
OPPOSITION- Lisa Truchan, Rika Jolie, Paul Runnels, David McGavin, "Eighteen Week Duration of Immunity in Pigs Vaccinated at 3 or 8 Weeks of Age with One Dose of a Mycoplasma hyopneumoniae Bacterin", PROCEEDINGS OF THE AMERICAN ASSOCIATION OF SWINE PRACTITIONERS CONFERENCE 2000; INDIANAPOLIS, INDIANA; MARCH 11-14, 2000, (20000311), page 125, XP002734481
OPPOSITION- Marlin Hoogland, Opriessnig, Halbur, "Effects of adjuvants on porcine circovirus type 2-associated lesions", Journal of Swine Health and Production, (20060501), vol. 14, no. 3, pages 133 - 139, XP055031472
OPPOSITION- Merrill L. Schaeffer, "Declaration of Merrill L. Schaeffer PhD.", Declaration, (20190320), pages 1 - 14, XP055789570
OPPOSITION- Michael B Roof, Kelly Burkhart and Federico A Zuckerman, "Evaluation of the immune response and efficacy of 1 and 2 dose commercial Mycoplasma hyopneumoniae bacterins", AASV, (20010101), pages 163 - 167, AASV, (20181018), XP055516930
OPPOSITION- Michael Haake; Andreas Palzer; Beate Rist; Christiane Weissenbacher-Lang; Vicky Fachinger; Alex Eggen; Mathias Ritzmann; Matthias Eddicks, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Veterinary Microbiology, (20130000), vol. 168, pages 1 - 9, XP055502963
OPPOSITION- NAWAGITGUL P, ET AL., "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", Journal of General Virology, (20000101), vol. 81, no. 9, ISSN 0022-1317, pages 2281 - 2287, XP002978778
OPPOSITION- Pat Halbur, Opriessnig Tanja, "Porcine Circovirus Associated Disease (PCVAD)… a "Double Bogey"", Carthage Veterinary Service Ltd. 16th Annual Swine Conference, (20060101), pages 1 - 71, Carthage Veterinary Service Ltd. 16th Annual Swine Conference, URL: http://www.prairieswine.com/pdf/36144.pdf, (20160602), XP055277398
OPPOSITION- Reynaud, Et Al., "Safety of a high dose administration of an inactivated adjuvanted PCV2 vaccine in conventional gilts", IPVS, (20040101), page 87, IPVS, URL: https://www.aasv.org/library/swineinfo/Content/IPVS/2004/709.pdf, (20181018), XP055516942
OPPOSITION- Salmon, Et Al., "Developmental and Comparative Immunology", Dev. Comp. Immunol., (20090101), vol. 33, pages 384 - 393, XP055516948
OPPOSITION- Salmon, "Immunité chez le foetus et le nouveau-né: modèle porcin", Reprod. Nutr. Developpement, (19840101), vol. 24, pages 197 - 206, XP055516981
OPPOSITION- VOLKER GERDTS et al, "Fetal immunization by DNA vaccine delivered into the oral cavity", Nat. Med., (20000801), vol. 6, no. 8, pages 929 - 932, XP055516967
OPPOSITION- Volker Gerdts et al, "Oral DNA Vaccination In Utero Induces Mucosal Immunity and Immune Memory in the Neonate", The Journal of Immunology, Williams & Wilkins Co., US, US, (20020215), vol. 168, no. 4, ISSN 0022-1767, pages 1877 - 1885, XP055516960
OPPOSITION- WEINGARTL, "Porcine circovirus structure and replication : a minireview", Agricultura, (20020000), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- Weingartl, "Porcine circovirus structure and replication a minireview", Agricultura, (20020101), pages 11 - 14, Agricultura, (20160802), XP055292683
OPPOSITION- G. M. Allan, F. McNeilly, J, Ellis, S. Krakowka, B. Meehan, I. McNair, L. Walker, S. Kennedy, "Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication", Archive Virology, (20141205), vol. 145, no. 11, pages 2421 - 2429, XP035411151
OPPOSITION- Nielsen, J. ; Ronsholt, L. ; Sorensen, K.J., "Experimental in utero infection of pig foetuses with porcine parvovirus (PPV)", VETERINARY MICROBIOLOGY, Elsevier BV, NL, NL, (19910601), vol. 28, no. 1, doi:10.1016/0378-1135(91)90095-W, ISSN 0378-1135, pages 1 - 11, XP023915174
OPPOSITION- Michael Haake et al, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Veterinary microbiology, Elsevier, (20140101), vol. 168, no. 2-4, doi:10.1016/j.vetmic.2013.11.012, ISSN 03781135, pages 272 - 280, XP055155313
OPPOSITION- Bachmann, M.F. Zinkernagel, R.M., "The influence of virus structure on antibody responses and virus serotype formation", IMMUNOLOGY TODAY., ELSEVIER PUBLICATIONS, CAMBRIDGE., GB, GB, (19961201), vol. 17, no. 12, doi:10.1016/S0167-5699(96)10066-9, ISSN 0167-5699, pages 553 - 558, XP004071007
OPPOSITION- Liljeqvist, S. Stahl, S., "Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines", Journal of Biotechnology, Elsevier, Amsterdam NL, Amsterdam NL, (19990730), vol. 73, no. 1, doi:10.1016/S0168-1656(99)00107-8, ISSN 0168-1656, pages 1 - 33, XP004180163
OPPOSITION- Moraes, M.P. Mayr, G.A. Mason, P.W. Grubman, M.J., "Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20020222), vol. 20, no. 11-12, doi:10.1016/S0264-410X(01)00483-2, ISSN 0264-410X, pages 1631 - 1639, XP004340386
OPPOSITION- NOAD R, ROY P, "Virus-like particles as immunogens", Trends in Microbiology, ELSEVIER SCIENCE LTD., KIDLINGTON., GB, GB, (20030901), vol. 11, no. 9, doi:10.1016/S0966-842X(03)00208-7, ISSN 0966-842X, pages 438 - 444, XP003004438
OPPOSITION- T. Opriessnig et al, "Comparison of Molecular and Biological Characteristics of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Vaccine (Ingelvac PRRS MLV), the Parent Strain of the Vaccine (ATCC VR2332), ATCC VR2385, and Two Recent Field Isolates of PRRSV", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US, (20021201), vol. 76, no. 23, doi:10.1128/JVI.76.23.11837-11844.2002, ISSN 0022-538X, pages 11837 - 11844, XP002997173
OPPOSITION- Rovira A., M. Balasch, J. Segales, L. Garcia, J. Plana-Duran, C. Rosell, H. Ellerbrok,A. Mankertz, M. Domingo, "Experimental Inoculation of Conventional Pigs with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus 2", Journal of Virology, (20020401), vol. 76, no. 7, pages 3232 - 3239, XP055527104
OPPOSITION- FENAUX M, ET AL., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US, (20040601), vol. 78, no. 12, doi:10.1128/JVI.78.12.6297-6303.2004, ISSN 0022-538X, pages 6297 - 6303, XP008039321
OPPOSITION- FENAUX M. , T. Opriessnig, P. G. Halbur, F. Elvinger, and X. J. Meng, "A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs", Journal of Virology, (20040601), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- Dawson A et al, "STUDIES OF THE FIELD EFFICACY AND SAFETY OF A SINGLE-DOSE MYCOPLASMA HYOPNEUMONIAE VACCINE FOR PIGS", VETERINARY RECORD, BRITISH VETERINARY ASSOCIATION, LONDON, GB, GB, (20021102), vol. 151, no. 18, doi:10.1136/vr.151.18.535, ISSN 0042-4900, pages 535 - 538, XP008048796
OPPOSITION- S. Krakowka, J. A. Ellis, F. Mcneilly, S. Ringler, D. M. Rings, G. Allan, "Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2)", VETERINARY PATHOLOGY., AMERICAN COLLEGE OF VETERINARY PATHOLOGISTS, US, US, (20010101), vol. 38, no. 1, doi:10.1354/vp.38-1-31, ISSN 0300-9858, pages 31 - 42, XP055277395
OPPOSITION- Boisg�rault F; Moron G; Leclerc C, "Virus-like particles: a new family of delivery systems", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, GB, (20020101), vol. 1, no. 1, doi:10.1586/14760584.1.1.101, ISSN 1476-0584, pages 101 - 109, XP008099122
SEARCH- BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20031107), vol. 21, no. 31, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [A] 1,17 * page 4567; tables 1, 2 * * page 4569 - page 4570; tables 3, 4 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents